Fig. 5: Treatment outcomes and number of fusion events.
From: Prognostic value of structural variants in early breast cancer patients
a Number of fusions between non-pathologic complete response(pCR) (n = 109) and pCR (n = 52) in all subtypes, b Number of fusions between non-pathologic complete response(pCR) (n = 31) and pCR (n = 7) in HR + HER2- BC. c Number of fusions between non-pathologic complete response(pCR) (n = 13) and pCR (n = 13) in HR + HER2 + BC. d Number of fusions between non-pathologic complete response(pCR) (n = 10) and pCR (n = 10) in HR-HER2 + BC and (e) number of fusions between non-pathologic complete response(pCR) (n = 55) and pCR (n = 22) in triple-negative breast cancer (TNBC). f Kaplan-Meier (KM) for event-free survival (EFS) according to high vs. low number of fusions (cut-off value: 0.6) in all subtypes (n = 197). g KM for EFS in HR + HER2- BC (n = 38), h KM for EFS in HR + HER2 + BC (n = 26). i KM for EFS in HR-HER2 + BC (n = 20) and (j) KM for EFS in TNBC (n = 113).
